Dallas-based Baylor Scott & White Health posted $634 million in operating income (8.3% margin) for the first six months of fiscal year 2024, which ended Dec. 31, 2023, an improvement on the operating income of $561 million (8.2% margin) over the same period of fiscal year 2023.
